Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review.
Anna M DornischAllison Y ZhongDarren M C PoonAlison C TreeTyler M SeibertPublished in: World journal of urology (2024)
There is strong evidence that it is possible to improve oncologic outcomes without substantially increasing toxicity through MR-guided focal boost, at least in the setting of a 35-fraction radiotherapy regimen. Barriers to clinical practice implementation are addressable through additional investigation and new technologies.
Keyphrases
- prostate cancer
- radical prostatectomy
- early stage
- clinical practice
- locally advanced
- rectal cancer
- radiation therapy
- contrast enhanced
- radiation induced
- magnetic resonance
- primary care
- healthcare
- oxidative stress
- magnetic resonance imaging
- quality improvement
- squamous cell carcinoma
- robot assisted
- computed tomography
- light emitting